Iridium Medical Technology Company (IMTC) is an innovative neuron-electronic interface company, and the first to develop a high-acuity spherical bionic retina HARP4k. HARP4k, IMTC’s contact-lens-shaped wireless retinal prosthesis for retinal blindness caused by Retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD), is a 30µm-thick packaged wireless implant with integrated camera chip, convolutional image processor and a high-density 4,000-microelectrode array interfacing to the retinal neurons. HARP4k supports the acuity needed for recognizing faces and objects, reading big-print books (font size > 14 pt.), and navigating through life.

Iridium Medical Technology Company (IMTC) has developed a high-definition spherical bionic retina for patients who have lost their vision due to retinal diseases. This bionic retina has been productized and entered human clinical trials. By leveraging Taiwan’s strengths in electronics and medical technology, IMTC aims to create a world-class Class III implantable medical device, positioning Taiwan’s high-end medical technology to compete in the global market.

No related news